Press Releases Poolbeg Pharma PLC

Equities

POLB

GB00BKPG7Z60

Biotechnology & Medical Research

Delayed London S.E. Other stock markets 02:11:20 17/02/2026 pm IST			5-day change	1st Jan Change
4.865 ^GBX	+3.51%		+5.76%	+21.62%

26/12	Certain Ordinary Shares of Poolbeg Pharma PLC are subject to a Lock-Up Agreement Ending on 26-DEC-2025.	CI
08/12	Poolbeg Pharma plc Announces the POLB 001 Trial Is to Feature in Cancer Immunotherapy-Induced CRSResearch Programme	CI

Press Releases

23/25/23	POLB 001: tackling cytokine storms before they start	AQ
19/25/19	Form 8.5 (EPT/RI) - Poolbeg Pharma Plc	AQ
05/25/05	Form 8.5 (EPT/RI) - Poolbeg Pharma Plc	AQ
21/25/21	Form 8.5 (EPT/RI) - Poolbeg Pharma Plc	AQ
03/25/03	Form 8.5 (EPT/RI) - Poolbeg Pharma Plc	AQ
22/24/22	University College Dublin : UCD leading on research collaborative agreements with industry, according to latest Knowledge Transfer Ireland Survey	AQ
29/24/29	Poolbeg Pharma plc - Voluntary Delisting from OTCQB Market	AQ
10/24/10	Poolbeg Pharma plc - Annual Report and AGM Notice	AQ
08/24/08	Poolbeg Pharma's POLB 001 immuno-modulator II receives fully-granted patent from US Patent Office	AQ
01/24/01	Poolbeg Pharma and Silk Road Therapeutics announce strategic collaboration on novel orphan drug	AQ
01/24/01	Poolbeg Pharma plc - Appointment of Joint Broker	AQ
23/24/23	Poolbeg Pharma plc - Director Share Purchase	AQ
20/24/20	Poolbeg Pharma plc - Director Share Purchase	AQ
20/24/20	Poolbeg Pharma chair discusses shift to executive role; hVIVO share sale	AQ
12/24/12	Poolbeg Pharma says research confirms $10B plus opportunity for POLB 001 in cancer immunotherapies	AQ
08/24/08	Poolbeg Pharma's new VP of Clinical Operations Laura Maher aims to help progress development assets	AQ
18/24/18	Poolbeg Pharma plc - Further Data Confirms POLB 001's Potential in Cancer Immunotherapy-Induced Cytokine Release Syndrome	AQ
12/23/12	Poolbeg Pharma plc - POLB 001 Data Presented at ASH	AQ
22/23/22	Poolbeg Pharma plc - Immunomodulator II patent granted in Japan	AQ
17/23/17	Poolbeg Pharma plc - POLB 001 LPS Challenge Trial Data to be presented at IUIS	AQ
02/23/02	Poolbeg Pharma "continuing its campaign to find a partner" for POLB001	AQ
18/23/18	Poolbeg Pharma unveils new collaboration agreement	AQ
13/23/13	Poolbeg Pharma "moving forward rapidly" with POLB001	AQ
29/23/29	Poolbeg Pharma and CytoReason identify "very exciting influenza targets"	AQ
22/23/22	Poolbeg Pharma sees "significant commercial opportunity" in oral vaccines	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

Press Releases Poolbeg Pharma PLC

Equities

POLB

GB00BKPG7Z60

Biotechnology & Medical Research

Press Releases

Filters